Number of Shares
500,000.00
Current Holdings Value*
$18.11 Mil
% of Portfolio
1.29%
Total Estimate Gain
$-5.37 Mil
% of Total Estimate Gain
-4.70%

Vestal Point Capital, LP's Ultragenyx Pharmaceutical Inc Holding Summary

As of 2025-03-31, Vestal Point Capital, LP held 500,000.00 shares of Ultragenyx Pharmaceutical Inc(RARE), totaling $18.11 Mil. This investment constitutes 1.29% of their stock portfolio, and Vestal Point Capital, LP now holds 0.53% of the outstanding Ultragenyx Pharmaceutical Inc(RARE) stock.

The initial trade took place in 2024Q1. And since then Vestal Point Capital, LP has made 3 purchases of RARE, at an average price of $44.89, for a total of 2.55 Mil shares. In addition, there have been 2 sales at an average price of $46.38 for 2.05 Mil shares. Based on historical transaction data and RARE's current price of $28.03, Vestal Point Capital, LP's estimated gain on his RARE holdings is $-5.37 Mil, reflecting a -4.70% gain to date.

Vestal Point Capital, LP RARE ($28.03) Holding Chart

Vestal Point Capital, LP RARE ($28.03) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1